Hepatocellular carcinoma (HCC), also called malignant hepatoma, is one of the deadliest
cancers due to its complexities, reoccurrence after surgical resection, metastasis and …

Liver cancer is one of the most common cancers worldwide and is also one of the most
difficult cancers to treat, resulting in almost one million deaths per year, and the danger of …

Hepatocellular carcinoma (HCC) is one of the deadliest cancers due to its complexities,
reoccurrence after surgical resection, metastasis and heterogeneity. In addition to sorafenib …

Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid, obtained from the
plant Glycyrrhiza glabra, have numerous pharmacological activities, such as anti …

Glycyrrhetinic acid (GA), the main hydrolysate of glycyrrhizic acid extracted from the root of
licorice, has been used in hepatocellular carcinoma (HCC) therapy. Particularly, GA as a …

Enhanced cancer treatment remains as one of the focused areas for researchers around the
world. Hence, the progress in this direction will be a challenge and an opportunity in, inter …

Liver cancer is one of the most common causes of cancer mortality worldwide.
Chemotherapy and radiotherapy are the conventional therapies generally employed in …

The development of nanomedicines for the treatment of cancer focuses on the local targeted
delivery of chemotherapeutic drugs to enhance drug efficacy and reduce adverse effects …

The first description of the medical use of licorice appeared in “Shennong Bencao Jing”, one
of the well-known Chinese herbal medicine classic books dated back to 220–280 AD. As …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer‐associated deaths
worldwide. There is a lack of efficient therapy for HCC; the only available first‐line systemic …